Ebert, E. C., Panja, A., Das, K. M., Praveen, R., Geng, X., Rezac, C., & Bajpai, M. (2009). Patients with inflammatory bowel disease may have a transforming growth factor-β-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies. Blackwell Science Inc.

Ebert, E C., A. Panja, K M. Das, R. Praveen, X. Geng, C. Rezac, and M. Bajpai. Patients With Inflammatory Bowel Disease May Have a Transforming Growth Factor-β-, Interleukin (IL)-2- or IL-10-deficient State Induced By Intrinsic Neutralizing Antibodies. Blackwell Science Inc, 2009.

Ebert, E C., et al. Patients With Inflammatory Bowel Disease May Have a Transforming Growth Factor-β-, Interleukin (IL)-2- or IL-10-deficient State Induced By Intrinsic Neutralizing Antibodies. Blackwell Science Inc, 2009.